Apotex Doesn't Infringe Patent For Benicar, Judge Says
A federal judge ruled Friday that Apotex's planned generic version of Daiichi Sankyo's blood pressure drug Benicar does not infringe a patent that Daiichi previously disclaimed, a decision that could reduce...To view the full article, register now.
Already a subscriber? Click here to view full article